ERJ Open Research

Papers
(The H4-Index of ERJ Open Research is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Social support and recovery in ARDS survivors: a prospective cohort study152
Penetrance of interstitial lung disease and lung cancer in carriers ofSFTPA1orSFTPA2pathogenic variants105
Development and external validation of a model for lung transplantation-free survival prediction of primary Sjögren's syndrome-associated interstitial lung disease: a prospective cohort study85
ERS Congress 2024: Highlights from the respiratory infections assembly82
Role of pulmonary rehabilitation in extracellular matrix protein expression in vastus lateralis muscle in atrophic and nonatrophic patients with COPD71
Artificial intelligence augmentation raises questions about the future of bronchoscopy70
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw49
Decoding the impact of the placebo response in clinical trials for chronic cough43
Diagnosis of pulmonary embolism in patients with haemoptysis: the POPEIHE study42
Altered ventricular repolarisation dynamic: the missing link between obstructive sleep apnoea and sudden death?38
Williams–Campbell syndrome case series and discordant twins38
DElaying disease Progression In COPD with early escalation to Triple therapy – A Modelling Study (DEPICT-2)38
Myostatin and smad2/smad3 pathway define a differential clinical phenotype in Copd-associated Sarcopenia37
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era36
Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models35
Endobronchial valve treatment improves diaphragm function in severe emphysema patients34
Association of MYH10 with clinical variables in obstructive lung diseases34
Exploring the roles of airway dipeptidyl peptidase 1 in obstructive airway disease34
PROTEA study: a protocol for a randomised controlled trial evaluating the efficacy, immune effects and cost-effectiveness of oral bacterial lysate (OM-85) therapy to protect moderate-late preterm infa31
Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?29
An exploratory study evaluating the use of coping strategies while driving in obstructive sleep apnoea syndrome patients and controls28
Causes of ventilatory inefficiency in lung resection candidates28
Progression of Interstitial Lung Disease After the Envisia Genomic Classifier28
COVID-19-related organising pneumonia in patients with secondary antibody deficiency responds to immune globulin27
ERS International Congress 2021: highlights from the Epidemiology and Environment Assembly26
An observational study ofPseudomonas aeruginosain adult long-term ventilation26
ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly26
0.35512900352478